GAIN THERAPEUTICS, INC: 10-Q filed 2022-08-08

Name: GAIN THERAPEUTICS, INC: 10-Q filed 2022-08-08
Creator: GAIN THERAPEUTICS, INC

What GAIN THERAPEUTICS, INC reported in its quarterly report filed 2022-08-08 (fiscal Q2 2022): 43 published measures, 117 facts as tagged in accession 0001558370-22-012533.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-08-08
Fiscal period: fiscal Q2 2022
Accession: 0001558370-22-012533 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GAIN THERAPEUTICS, INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-06-30	31,890,036	USD
At 2021-12-31	38,985,071	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-06-30	4,873,381	USD
At 2021-12-31	4,167,525	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-06-30	27,016,655	USD
At 2022-03-31	31,827,791	USD
At 2021-12-31	34,817,546	USD
At 2021-06-30	41,388,904	USD
At 2021-03-31	44,464,009	USD
At 2020-12-31	6,201,989	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-06-30	14,305,949	USD
At 2021-12-31	36,880,673	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-5,085,420	USD	91
2022-01-01 to 2022-06-30	-8,358,063	USD	181
2021-04-01 to 2021-06-30	-3,556,693	USD	91
2021-01-01 to 2021-06-30	-6,007,140	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-7,498,450	USD	181
2021-01-01 to 2021-06-30	-6,026,967	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	52,376	USD	181
2021-01-01 to 2021-06-30	50,991	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	95,102	USD	91
2022-01-01 to 2022-06-30	140,108	USD	181
2021-04-01 to 2021-06-30	89,173	USD	91
2021-01-01 to 2021-06-30	94,441	USD	181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	95,102	USD	91
2022-01-01 to 2022-06-30	132,640	USD	181
2021-04-01 to 2021-06-30	81,617	USD	91
2021-01-01 to 2021-06-30	81,617	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-36,611	USD	181
2021-01-01 to 2021-06-30	41,776,510	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-14,897,232	USD	181
2021-01-01 to 2021-06-30	-50,991	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-06-30	-20,925,459	USD
At 2021-12-31	-7,034,853	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	11,883,368	shares	91
2022-01-01 to 2022-06-30	11,883,368	shares	181
2021-04-01 to 2021-06-30	11,876,460	shares	91
2021-01-01 to 2021-06-30	8,431,410	shares	181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	11,883,368	shares	91
2022-01-01 to 2022-06-30	11,883,368	shares	181
2021-04-01 to 2021-06-30	11,876,460	shares	91
2021-01-01 to 2021-06-30	8,431,410	shares	181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-0.43	USD/shares	91
2022-01-01 to 2022-06-30	-0.7	USD/shares	181
2021-04-01 to 2021-06-30	-0.3	USD/shares	91
2021-01-01 to 2021-06-30	-0.71	USD/shares	181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-0.43	USD/shares	91
2022-01-01 to 2022-06-30	-0.7	USD/shares	181
2021-04-01 to 2021-06-30	-0.3	USD/shares	91
2021-01-01 to 2021-06-30	-0.71	USD/shares	181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	9,146	USD	91
2022-01-01 to 2022-06-30	10,823	USD	181
2021-04-01 to 2021-06-30	3,660	USD	91
2021-01-01 to 2021-06-30	7,138	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-06-30	138,909	USD
At 2021-12-31	105,986	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	612,095	USD	181
2021-01-01 to 2021-06-30	302,286	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-5,176,385	USD	91
2022-01-01 to 2022-06-30	-8,464,862	USD	181
2021-04-01 to 2021-06-30	-3,514,563	USD	91
2021-01-01 to 2021-06-30	-5,981,480	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-06-30	25,833,090	USD
At 2021-12-31	37,722,044	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-06-30	3,410,058	USD
At 2021-12-31	2,552,546	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-06-30	948,902	USD
At 2021-12-31	560,479	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	5,271,487	USD	91
2022-01-01 to 2022-06-30	8,604,970	USD	181
2021-04-01 to 2021-06-30	3,603,736	USD	91
2021-01-01 to 2021-06-30	6,075,921	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	2,582,224	USD	91
2022-01-01 to 2022-06-30	4,138,664	USD	181
2021-04-01 to 2021-06-30	1,793,508	USD	91
2021-01-01 to 2021-06-30	3,215,018	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-06-30	11,883,368	shares
At 2021-12-31	11,883,368	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2022-06-30	14,335,784	USD
At 2021-12-31	36,911,952	USD
At 2021-06-30	43,204,652	USD
At 2020-12-31	7,504,281	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-06-30	56,444,556	USD
At 2021-12-31	55,832,461	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2022-06-30	-145,568	USD
At 2021-12-31	-90,645	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-06-30	745,884	USD
At 2021-12-31	901,042	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2022-06-30	760,945	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2022-06-30	626,010	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2022-06-30	176,601	USD
At 2021-12-31	134,375	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2022-06-30	37,692	USD
At 2021-12-31	28,389	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2022-06-30	1,070,396	USD
At 2021-12-31	681,770	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2022-06-30	1,456,059	USD
At 2021-12-31	727,785	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-5,076,274	USD	91
2022-01-01 to 2022-06-30	-8,347,240	USD	181
2021-04-01 to 2021-06-30	-3,553,033	USD	91
2021-01-01 to 2021-06-30	-6,000,002	USD	181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-8,358,063	USD	181
2021-01-01 to 2021-06-30	-6,007,140	USD	181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-5,116,686	USD	91
2022-01-01 to 2022-06-30	-8,412,986	USD	181
2021-04-01 to 2021-06-30	-3,563,950	USD	91
2021-01-01 to 2021-06-30	-6,018,560	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	2,689,263	USD	91
2022-01-01 to 2022-06-30	4,466,306	USD	181
2021-04-01 to 2021-06-30	1,810,228	USD	91
2021-01-01 to 2021-06-30	2,860,903	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	11,504	USD	181
2021-01-01 to 2021-06-30	5,561	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	28,230	USD	181
2021-01-01 to 2021-06-30	5,561	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	344,618	USD	181

Inspect the source

Entity: GAIN THERAPEUTICS, INC / CIK 0001819411
Captured: 2026-09-21T17:29:03.692Z
SEC response SHA-256: 095d94270c60df2798bdd729e7c6af622e315c1c0ad85d6e4622b86179355b54

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001819411.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))